Simplex Trading
LABU icon

Simplex Trading’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Simplex Trading’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,048
Closed -$392K – 9116
2024
Q3 		$392K Sell
3,048
-19,638
-87% -$2.56M ﹤0.01% 3857
2024
Q2 		$2.57M Buy
+22,686
New +$2.43M ﹤0.01% 1974
2024
Q1 		– Sell
-1,275
Closed -$155K – 9380
2023
Q4 		$155K Sell
1,275
-11,189
-90% -$856K ﹤0.01% 4935
2023
Q3 		$949K Buy
+12,464
New +$1.28M ﹤0.01% 2715
2023
Q2 		– Sell
-1,107
Closed -$108K – 9490
2023
Q1 		$108K Sell
1,107
-234
-17% -$31.7K ﹤0.01% 5064
2022
Q4 		$189K Sell
1,341
-52,945
-98% -$7.38M ﹤0.01% 4298
2022
Q3 		$7.61M Sell
54,286
-6,241
-10% -$1.14M 0.01% 927
2022
Q2 		$8.16M Buy
60,527
+53,196
+726% +$9.06M 0.01% 893
2022
Q1 		$2.3M Buy
7,331
+3,691
+101% +$1.39M ﹤0.01% 1965
2021
Q4 		$2.62M Buy
3,640
+3,183
+696% +$3.05M ﹤0.01% 1762
2021
Q3 		$716K Buy
457
+97
+27% +$119K ﹤0.01% 3563
2021
Q2 		$530K Sell
360
-1,445
-80% -$2M ﹤0.01% 4068
2021
Q1 		$2.85M Buy
1,805
+1,046
+138% +$2.45M 0.01% 1264
2020
Q4 		$1.52M Buy
+759
New +$1.21M ﹤0.01% 2049
2020
Q2 		– Sell
-717
Closed -$323K – 7984
2020
Q1 		$323K Buy
717
+687
+2,290% +$625K ﹤0.01% 3067
2019
Q4 		$34K Sell
30
-565
-95% -$507K ﹤0.01% 5552
2019
Q3 		$367K Buy
+595
New +$494K ﹤0.01% 2945
2019
Q2 		– Sell
-639
Closed -$765K – 7466
2019
Q1 		$765K Buy
639
+280
+78% +$291K ﹤0.01% 2224
2018
Q4 		$235K Buy
+359
New +$376K ﹤0.01% 2965
2017
Q4 		– Sell
-118
Closed -$201K – 6336
2017
Q3 		$201K Sell
118
-95
-45% -$132K 0.01% 1186
2017
Q2 		$268K Buy
213
+31
+17% +$31.3K 0.01% 1014
2017
Q1 		$174K Buy
+182
New +$162K 0.01% 1313

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Simplex Trading's LABU Position: Q4 2024 in Review

Simplex Trading sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2024, closing a stake of 3,048 shares — an estimated $392K sold.

Simplex Trading first reported a position in LABU in Q1 2017 and held it in 22 quarters. The position peaked at $8.16M in Q2 2022. 37 funds tracked by Wall St. Rank hold LABU as of Q4 2024.

  • Simplex Trading reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2024 after selling out during the quarter.
  • Simplex Trading sold 3,048 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2024, an estimated $392K.
  • Simplex Trading first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2017 and held it in 22 quarters.
  • Simplex Trading's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $8.16M in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.